Effector and memory T-cell differentiation: implications for vaccine development
The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Abstract
Recent work shows that after stimulation with antigen, CD4+ and CD8+ T cells embark on a programme of proliferation that is closely linked with the acquisition of effector functions and leads ultimately to memory-cell formation. Here, we discuss the signals required for commitment to this programme of development and the factors that might influence its progression. Models of the pathways of effector and memory T-cell differentiation are discussed, and we highlight the implications of this new understanding for the optimization of vaccine strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The relatively few naïve T-cells during early reconstitution is consistent with programmed recovery in patients following chemotherapy [39, 40], immune checkpoint blockade [20, 24], or after infection [41, 42].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [41]
In the citing paper
“These kinetics are consistent with a typical T cell response after the effector phase (53).”
From mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern (2021) · cites this paper as [53]
In the citing paper
“the central memory (CM) or effector memory (EM) differentiation states of CD4+ and CD8+ T cells have implications for durability, recirculation, tissue access, and responses upon antigen re-exposure (Kaech et al., 2002; Martin and Badovinac, 2018; Wherry et al., 2003).”
From Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination (2021) · cites this paper as Kaech et al., 2002
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationPreferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Self-citationImmunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Stages of T-cell responses The path towards memory T-cell development continues to be delineated, but there are clearly three stages that T cells pass through as they differentiate into memory cell”
Self-citationOut of Eden: Stem Cells and Their Niches
Watt, F. M., & Hogan, A. B. L. M. (2000) · Science · doi:10.1126/science.287.5457.1427 · Cited by 1,758
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Research works printed but not linked: 1
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Items 701–800 of 1,003
Lu, C., Wu, C.-J., Chan, C.-C., Nguyen, D. T., Lin, K.-R., Lin, S., Chen, L., Yen, J. J.-Y., & Kuo, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00488 · Cited by 36
Albaghdadi, H., Robinson, N., Finlay, B., Krishnan, L., & Sad, S. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0900843 · Cited by 38
“Secondly, CD8 T cell response does not develop by day 7 (34, 37), a time period when CD8 T cell response peaks in most infection models (8).”
BackgroundGautam, N., Sankaran, S., Yason, J. A., Tan, K. S. W., & Gascoigne, N. R. J. (2017) · Methods · doi:10.1016/j.ymeth.2017.11.015 · Cited by 41
“Another small subset of T cells derived from TN cells differentiates into long lived TM cells, which helps in mediating a quicker and enhanced immune response upon subsequent exposure to the same antigen [4,5].”
BackgroundRizzo, M. D., Henriquez, J. E., Blevins, L. K., Bach, A. P., Crawford, R. B., & Kaminski, N. E. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09918-7 · Cited by 36
“This is likely due to the hierarchal nature of the acquisition of effector function by CD8+ T cells (Rothenberg et al. 1991; Kaech et al. 2002).”
Continuous Label-Free Electronic Discrimination of T Cells by Activation State
Han, P., Yosinski, S., Kobos, Z. A., Chaudhury, R., Lee, J. S., Fahmy, T. M., & Reed, M. A. (2020) · ACS Nano · doi:10.1021/acsnano.0c03018 · Cited by 36
Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates
Tseng, C., Wang, W. X., Douglas, T. R., & Chou, L. Y. T. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101844 · Cited by 36
Nuclear Sirtuins and the Aging of the Immune System
Gámez-García, A., & Vázquez, B. N. (2021) · Genes · doi:10.3390/genes12121856 · Cited by 40
“Helper CD4+ T cells have immunomodulatory functions and are further divided into myriad subsets, including Th1, Th2, Th9, Th17, and Treg, each of which has a distinctive group of immune cell targets and cytokine expression pattern (Figure 2) [88,89].”
BackgroundWells, A. C., Hioki, K. A., Angelou, C. C., Lynch, A. C., Liang, X., Ryan, D. J., Thesmar, I., Zhanybekova, S., Žuklys, S., Ullom, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40959-7 · Cited by 35
Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids
Bauer, H., Darji, A., Chakraborty, T., & Weiss, S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302423 · Cited by 35
Powell, T. J., Brown, D. M., Hollenbaugh, J. A., Charbonneau, T. T., Kemp, R. A., Swain, S. L., & Dutton, R. W. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.006 · Cited by 35
Problems and emerging approaches in HIV/AIDS vaccine development
Titti, F., Cafaro, A., Ferrantelli, F., Tripiciano, A., Moretti, S., Caputo, A., Gavioli, R., Ensoli, F., Robert-Guroff, M., Barnett, S. W., et al. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.1.23 · Cited by 35
CD8+ T cell responses: it's all downhill after their prime ...
Blattman, J. N., Cheng, L. E., & Greenberg, P. D. (2002) · Nature Immunology · doi:10.1038/ni0702-601 · Cited by 35
Perez‐Potti, A., Rodríguez-Pérez, M., Polo, E., Pelaz, B., & del Pino, P. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114829 · Cited by 40
Jia, B., Ng, S. K., DeGottardi, M. Q., Piatak, M., Yuste, E., Carville, A., Mansfield, K. G., Li, W., Richardson, B. A., Lifson, J. D., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000272 · Cited by 35
The clinical significance of memory T cells and its subsets in gastric cancer
Zhang, R., Li, F., Li, H., Yu, J., & Ren, X. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1066-5 · Cited by 37
CD3 + CD8 + CD28 − T Lymphocytes in Patients with Lupus Nephritis
Żabińska, M., Krajewska, M., Kościelska−Kasprzak, K., & Klinger, M. (2016) · Journal of Immunology Research · doi:10.1155/2016/1058165 · Cited by 38
Yang, Z., Wang, L., Wang, H., Shang, X., Niu, W., Li, J., & Wu, Y. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.026 · Cited by 34
Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7
Oosterhuis, K., Öhlschläger, P., van den Berg, J. H., Toebes, M., Gomez, R., Schumacher, T. N., & Haanen, J. B. A. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.25894 · Cited by 36
“Conventional CD8þ T-cell responses rapidly contract after the peak of the response has been reached, and levels of CD8þ T cells that remain after contraction are generally around 5% of peak levels.(41,42) In all our previous studies, immune responses”
BackgroundSecondary CD8 + T‐cell responses are controlled by systemic inflammation
Wirth, T. C., Martin, M. D., Starbeck-Miller, G. R., Harty, J. T., & Badovinac, V. P. (2011) · European Journal of Immunology · doi:10.1002/eji.201040730 · Cited by 42
A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory
Singh, A., & Suresh, M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407240 · Cited by 34
“According to the current axiom, mechanisms, which regulate the initial clonal burst size (expansion) and the ensuing clonal deletion (contraction) of antigen-specific effector CD8 T cells, are key determinants of the magnitude of CD8 T cell memory [24, 27, 43, 44].”
BackgroundPalucka, K., Dhodapkar, M. V., Paczesny, S., Ueno, H., Fay, J. W., & Banchereau, J. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000154249.74383.17 · Cited by 35
“Furthermore, this differs from the immune response induced by live virus, which appears to mobilize a considerable number of effectors for a short time, followed by a contraction of the antigen-specific T-cell pool as the virus has disappeared, and subsequent establishment of T-cell memory.(24,29) Alternatively, the s…”
BackgroundTuberculosis vaccines: the past, present and future
Wang, J., & Xing, Z. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.3.341 · Cited by 34
Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines
McFall-Boegeman, H., & Huang, X. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2029415 · Cited by 36
Bevilacqua, A., Franco, F., Lu, Y.-T., Rahiman, N., Kao, K., Chuang, Y., Zhu, Y., Held, W., Xie, X., Gunsalus, K. C., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adn2717 · Cited by 35
“The formation of antigen-specific memory CD8 + T cells plays a pivotal role in establishing long-term protection against previously encountered pathogens ( 7 , 8 ).”
Young, K. G., MacLean, S., Dudani, R., Krishnan, L., & Sad, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100695 · Cited by 35
“memory T cells, irrespective of their activation status (14, 18).”
BackgroundInfluentialMojumdar, K., Vajpayee, M., Chauhan, N. K., Singh, A., Singh, R., & Kurapati, S. (2011) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20610 · Cited by 36
“On antigen clearance, the effector population contracts, leaving behind a small but effective population of memory T cells which form the basis of ‘‘immunological memory’’ (7).”
Backgroundγ c deficiency precludes CD8 + T cell memory despite formation of potent T cell effectors
Decaluwe, H., Taillardet, M., Corcuff, E., Munitić, I., Law, H., Rocha, B., Rivière, Y., & Santo, J. P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913729107 · Cited by 33
“Upon recognition of pathogen-encoded peptides and appropriate costimulation, CD8 T cells undergo massive clonal expansion and activation with profound modifications in their gene expression profile, leading to the differentiation of potent antiviral effector cells (2).”
BackgroundRoychoudhuri, R., Lefebvre, F., Honda, M., Pan, L., Ji, Y., Klebanoff, C. A., Nichols, C. N., Fourati, S., Hegazy, A. N., Goulet, J.-P., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.007 · Cited by 38
Pham, N.-L. L., Badovinac, V. P., & Harty, J. T. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00004 · Cited by 33
“The critical role of direct signaling by IL-12 and/or type I IFNs in the responding CD8 T cells to optimize their survival during the expansion phase has been well documented (Curtsinger et al., 2005; Kolumam et al., 2005; Pearce and Shen, 2007; Cui et al., 2009; Xiao et al., 2009).”
BackgroundMethodTuzova, M. N., Richmond, J. M., Wolpowitz, D., Curiel‐Lewandrowski, C. N., Chaney, K. S., Kupper, T. S., & Cruikshank, W. W. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.919634 · Cited by 38
Impairment of CD4+ T Cell Polarization by Dengue Virus–Infected Dendritic Cells
Chase, A. J., Medina, F. A., & Muñoz‐Jordán, J. L. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir197 · Cited by 33
Lv, M., Li, S., Zhao, H., Wang, K., Chen, Q., Guo, Z., Liu, Z., & Xue, W. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02334k · Cited by 33
Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy
Jiang, D., Zhang, J.-P., Cheng, L., Zhang, G.-W., Li, Y., Li, Z., Lü, Z., Zhang, Z., Lu, Y., Zheng, L., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.011 · Cited by 33
Polymeric nucleic acid delivery for immunoengineering
Tzeng, S. Y., & Green, J. J. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.09.005 · Cited by 34
Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection
Cox, M. A., & Zajac, A. J. (2010) · BioMed Research International · doi:10.1155/2010/159152 · Cited by 40
Anfossi, N., Robbins, S. H., Ugolini, S., Georgel, P., Hoebe, K. H. N., Bouneaud, C., Ronet, C., Kaser, A., DiCioccio, C. B., Tomasello, E., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3773 · Cited by 37
Zheng, G., Wang, Y., Xiang, S.-H., Tay, Y., Wu, H., Watson, D., Coombes, J. D., Rangan, G. K., Alexander, S. I., & Harris, D. C. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020164 · Cited by 33
Kim, E., Ahn, S., Rhee, H.-I., & Lee, D. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.05.046 · Cited by 33
Braun, R. K., Foerster, M., Grahmann, P. R., Haefner, D., Workalemahu, G., & Kroegel, C. (2003) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.10021 · Cited by 33
“CD62LCCR7 are central memory cells and CD62LCCR7 are effector memory cells (20,21).”
BackgroundMonitoring T‐lymphocyte trafficking in tumors undergoing immune rejection
Hu, D., Kettunen, M. I., & Brindle, K. M. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20717 · Cited by 33
“The facility to detect migration of activated T cells into tumors in the clinic should be useful in evaluating the efficacy of these treatments and may also assist in the development of more effective anti-tumor vaccines (1,26).”
BackgroundKuss, I., Schaefer, C., Godfrey, T. E., Ferris, R. L., Harris, J. M., Gooding, W. E., & Whiteside, T. L. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.011 · Cited by 32
Tc1 effector diversity shows dissociated expression of granzyme B and interferon-γ in HIV infection
Kleen, T. O., Asaad, R. J., Landry, S. J., Boehm, B. O., & Tary‐Lehmann, M. (2004) · AIDS · doi:10.1097/00002030-200402200-00003 · Cited by 33
Qi, L., Li, Y., Zhang, L., Li, S., Zhang, X., Li, W., Qin, J., Chen, X., Ji, Y., Xue, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1297484 · Cited by 39
“CD8 T cells, CD14 monocytes, and CD16 monocytes are known to play critical roles in both cytotoxic and pro-in fl ammatory responses, contributing to immune defense against infections and regulation of in fl ammatory processes in different disease contexts (27, 28).”
Memory versus effector immune responses in oncolytic virotherapies
Macnamara, C. K., & Eftimie, R. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.04.004 · Cited by 38
Yoo, J., Galligan, C. L., Virtanen, C., & Fish, E. N. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091373 · Cited by 34
“In contrast, a prolonged period of Ag stimulation has been suggested to be required to induce Th2 polarization, because the capacity to produce IL-4 and IL-13 is acquired slowly (Iezzi et al., 1999; Kaech et al., 2002).”
BackgroundVitamin D Receptor Signals Regulate Effector and Memory CD8 T Cell Responses to Infections in Mice
Yuzefpolskiy, Y., Baumann, F. M., Penny, L. A., Studzinski, G. P., Kalia, V., & Sarkar, S. (2014) · Journal of Nutrition · doi:10.3945/jn.114.202895 · Cited by 32
Migration and T-lymphocyte effector function
Bradley, L. M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00043-8 · Cited by 31
Peripheral tolerance in CD8+ T cells
Srinivasan, M., & Frauwirth, K. A. (2009) · Cytokine · doi:10.1016/j.cyto.2009.01.010 · Cited by 45
Brimble, M. A., Kowalczyk, R., Harris, P. W. R., Dunbar, P. R., & Muir, V. J. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b712926b · Cited by 32
Chemokines: coded messages for T-cell missions
Viola, A., Molon, B., & Contento, R. L. (2008) · Frontiers in bioscience · doi:10.2741/3158 · Cited by 33
Nakamoto, Y., Suda, T., Momoi, T., & Kaneko, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3817 · Cited by 34
Khan, M. N., & Pichichero, M. E. (2013) · Infection and Immunity · doi:10.1128/iai.00313-13 · Cited by 32
Novel strategies to eliminate persistent viral infections
Martinic, M. M. A., & von Herrath, M. G. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.12.002 · Cited by 32
Moore, M. L., Brown, C. C., & Spindler, K. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.10060-10070.2003 · Cited by 33
Chikhlikar, P. R., de Arruda, L. B., Agrawal, S., Byrne, B. J., Guggino, W. B., August, J. T., & Marques, E. T. A. (2004) · Virology · doi:10.1016/j.virol.2004.02.025 · Cited by 32
“In contrast, CD8 T cells and B cells require continued antigen-specific expansion after primary infection or vaccination, with subsequent contraction in the absence of antigen (Kaech et al., 2002; Wherry et al., 2003).”
Wang, Y., Wang, L., Li, T., Ouyang, M., Xiong, H., & Zhou, D. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.028 · Cited by 34
“Effector memory T cells (T EM cells), which reside in both lymphoid and nonlymphoid tissues, can induce a strong immune memory protection effect by producing multiple cytokines like TNF-a and IFN-g upon a second encounter with the same antigen 57,58 .”
New insights into the biology of T-cell lymphomas
Iqbal, J., Inghirami, G. G., & Chan, W. C. (2024) · Blood · doi:10.1182/blood.2023021787 · Cited by 36
Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues.
Frasca, D., & Blomberg, B. B. (2011) · Europe PMC (PubMed Central) · Cited by 37
A capsule conjugate vaccine approach to prevent diarrheal disease caused byCampylobacter jejuni
Maue, A. C., Poly, F., & Guerry, P. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27985 · Cited by 31
“These differences include inocula size, duration of infection, and time to re-infection, all of which can affect the generation of long-lasting memory responses.(43,44) Thus, although homologous protection was not observed in humans re-challenged with CG8421, this should not diminish the value nor preclude the use of…”
BackgroundProfiling of Protein O -GlcNAcylation in Murine CD8 + Effector- and Memory-like T Cells
Aguilar, A. L., Gao, Y., Hou, X., Lauvau, G. S., Yates, J. R., & Wu, P. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00869 · Cited by 31
Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics
Du, Y., Fang, Q., & Zheng, S. G. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_1 · Cited by 34
The Effect of the Nanoparticle Shape on T Cell Activation
Oh, J., Xia, X., Wong, W., Wong, S. H. D., Yuan, W., Wang, H., Lai, N. C., Tian, Y., Ho, Y., Zhang, H., et al. (2022) · Small · doi:10.1002/smll.202107373 · Cited by 34
Aiello, A., Coppola, A., Ruggieri, S., Farroni, C., Altera, A. M. G., Salmi, A., Vanini, V., Cuzzi, G., Petrone, L., Meschi, S., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330175 · Cited by 31
“16 Memory T cells expand if re-challenged and contribute to prompt immune responses limiting initial viral replication, including that of the current variants, 40 41 and dissemination in the host, thereby preventing severe disease.”
Hamilton, S. E., Badovinac, V. P., Khanolkar, A., & Harty, J. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4012 · Cited by 31
“The degree of CD8 T cell-mediated protection after secondary infection depends on the quality and quantity of memory CD8 T cells (1, 8).”
BackgroundChen, H.-W., Liao, C.-H., Ying, C., Chang, C., & Lin, C.-M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.11.003 · Cited by 36
Gurjar, R. S., Gulley, S. L., & van Ginkel, F. W. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.08.002 · Cited by 31
“…or presence of cytolytic TEM, while IFN-c expression without GZMA expression in spleen is consistent with proliferating TCM. TEM reside at the ‘‘frontline’’ of pathogen invasion and initiate a quick response upon reinfection with the pathogen (Kaech et al., 2002; Masopust and Picker, 2012).”
BackgroundInfluentialGeneration and maintenance of human memory cells during viral infection
Halwani, R., Doroudchi, M., Yassine‐Diab, B., Janbazian, L., Shi, Y., Said, E. A., Haddad, E. K., & Sékaly, R. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0027-2 · Cited by 38
Intrinsic Role of FoxO3a in the Development of CD8+ T Cell Memory
Tzelepis, F., Joseph, J., Haddad, E. K., MacLean, S., Dudani, R., Agenès, F., Peng, S. L., Sékaly, R., & Sad, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200639 · Cited by 31
“C D8 T cells play a key protective role during infections that are caused by intracellular pathogens (1).”
BackgroundHandel, A., & Antia, R. (2008) · Journal of Virology · doi:10.1128/jvi.00653-08 · Cited by 31
“Since immunodominance is an important aspect of the dynamics of CTL responses, it is necessary to properly understand it, not only to gain fundamental insights into the functioning of immune responses but also for the design of T-cell-based vaccines and cancer treatments (6, 12, 15, 22).”
BackgroundCD40 Ligation In Vivo Induces Bystander Proliferation of Memory Phenotype CD8 T Cells
Koschella, M., Voehringer, D., & Pircher, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4804 · Cited by 31
“Rapid production of IFN- is a hallmark of memory CD8 T cells (27).”
BackgroundT Cell Development and Function
Adu‐Berchie, K., Obuseh, F. O., & Mooney, D. J. (2023) · Rejuvenation Research · doi:10.1089/rej.2023.0015 · Cited by 40
“39 The third model is a variation of the linear model, where the strength and duration of antigenic stimulation dictate the memory potential of the T cell: short antigen stimulation favors central memory, while longer stimulation favors effector memory and effector T cells.”
InfluentialAoki, H., Kitabatake, M., Abe, H., Xu, P., Tsunoda, M., Shichino, S., Hara, A., Ouji-Sageshima, N., Motozono, C., Ito, T., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113887 · Cited by 33
Designing live bacterial therapeutics for cancer
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115579 · Cited by 35
Systems biology applied to vaccine and immunotherapy development
Buonaguro, L., Wang, E., Tornesello, M. L., Buonaguro, L., & Marincola, F. M. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-146 · Cited by 33
“A subset of polarized activated effector T cells will further differentiate into long-lasting memory cells to readily induce an immune response at subsequent encounters with the same antigen [34].”
BackgroundKrzych, U., Dalai, S. K., Zarling, S., & Pichugin, A. V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00370 · Cited by 34
“…T cell pool in mice protected against malaria is consistent with an earlier view that virally induced memory CD8 T cells are organized into subsets on the basis of distinct functional activities and the maturation/activation status (Sallusto et al., 1999; Kaech et al., 2002; Wherry et al., 2003).”
BackgroundRyu, S. J., Jung, K. M., Yoo, H. S., Kim, T. W., Kim, S., Chang, J., & Choi, E. Y. (2009) · Blood · doi:10.1182/blood-2008-09-181263 · Cited by 30
Differential expression of mannose-6-phosphate receptor regulates T cell contraction
Ahmed, K. A., Wang, L., Griebel, P. J., Mousseau, D. D., & Xiang, J. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2hi0215-049rr · Cited by 30
“90%) effector CTLs die of activation-induced cell apoptosis, and the remaining 5–10% of CTLs become long-term memory CTLs capable of responding robustly on reencounter with the same Ag, leading to effective protection against the pathogenic infection [4].”
Backgroundde Jonge, J., Николаевна, И.-С. И., van Dijken, H., Spijkers, S., Mouthaan, J., de Jong, R., Smolonogina, T. A., Roholl, P. J. M., & Георгиевна, Р. Л. (2016) · Molecular Therapy · doi:10.1038/mt.2016.23 · Cited by 30
BPTF Is Essential for T Cell Homeostasis and Function
Wu, B., Wang, Y., Wang, C., Wang, G. G., Wu, J., & Wan, Y. Y. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600642 · Cited by 30
Duke, B. R., & Mitra‐Kaushik, S. (2019) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-019-09412-5 · Cited by 30
Opportunities for innovation: Building on the success of lipid nanoparticle vaccines
Huang, J. Y., Yuen, D., Mintern, J. D., & Johnston, A. P. R. (2021) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2021.101468 · Cited by 36
Toward improved immunocompetence of adoptively transferred CD8+ T cells
Speiser, D. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25427 · Cited by 30
Caetano, J., Martinho, A., Paiva, A. A., Pais, B., Valente, C., & Luxo, C. (2008) · Journal of Virology · doi:10.1128/jvi.02175-07 · Cited by 38
“Percentages of HCVcore-positive (A) and HCVNS3-positive (B) cells were measured ex vivo in chronically HCV-infected patients at five sequential time points: before treatment (0); at 1, 3, and 6 months of treatment; and 6 months after the end of therapy (12) (only six sustained-responder and four nonresponder patients…”
BackgroundMethodInfluentialHigh-throughput gene expression profiling of memory differentiation in primary human T cells
Haining, W. N., Angelosanto, J., Brosnahan, K., Ross, K. N., Hahn, C. K., Russell, K. E. R., Drury, L., Norton, S., Nadler, L. M., & Stegmaier, K. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-44 · Cited by 30
A review of the effectiveness of vaccine potency control testing
McVey, D. S., Galvin, J. E., & Olson, S. C. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00067-5 · Cited by 30
Homeostasis of the Memory T Cell Pool
Marsden, V. S., Kappler, J. W., & Marrack, P. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000090000 · Cited by 30
Turning immunological memory into amnesia by depletion of dividing T cells
Bellier, B., Thomas‐Vaslin, V., Saron, M., & Klatzmann, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936194100 · Cited by 34
Saito, K., Yajima, T., Kumabe, S., Doi, T., Yamada, H., Sad, S., Shen, H., & Yoshikai, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2496 · Cited by 30
Enhanced Expression of Cell Cycle Regulatory Genes in Virus-Specific Memory CD8 + T Cells
Latner, D. R., Kaech, S. M., & Ahmed, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.10953-10959.2004 · Cited by 30
Self-citationHoji, A., & Rinaldo, C. R. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02135.x · Cited by 32
Microneedle technology for potential SARS-CoV-2 vaccine delivery
McNamee, M., Wong, S., Guy, O. J., & Sharma, S. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2209718 · Cited by 31
Long-term exposure to decabrominated diphenyl ether impairs CD8 T-cell function in adult mice
Zeng, W., Wang, Y., Liu, Z., Khanniche, A., Hu, Q., Feng, Y., Ye, W., Yang, J., Wang, S., Zhou, L., et al. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.16 · Cited by 29
Liu, X., Alli, R., Steeves, M. A., Nguyen, P., Vogel, P., & Geiger, T. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200607 · Cited by 30
Onodera, A., Kokubo, K., & Nakayama, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02929 · Cited by 31
Jin, Y., Fayyaz, A., Liaqat, A., Khan, A., Alshammari, A., Wang, Y., Gu, R., & Wei, D. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106893 · Cited by 31
Immunotherapy for Bone and Soft Tissue Sarcomas
Uehara, T., Fujiwara, T., Takeda, K., Kunisada, T., Ozaki, T., & Udono, H. (2015) · BioMed Research International · doi:10.1155/2015/820813 · Cited by 32
“Although multimodal therapies including surgery, chemotherapy, and radiotherapy have improved clinical outcomes of patients with bone and soft tissue sarcomas, the prognosis of patients has plateaued over these 20 years.”
Viral Vaccines and CTL Response
Woolard, S., & Kumaraguru, U. (2010) · BioMed Research International · doi:10.1155/2010/141657 · Cited by 29
T-cell immunity generated by recombinant adenovirus vaccines
Yang, T. C., Millar, J., Grinshtein, N., Bassett, J. D., Finn, J. D., & Bramson, J. L. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.347 · Cited by 29
Smyth, K., Garcia, K., Sun, Z., Tuo, W., & Xiao, Z. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.10.019 · Cited by 31
Phenotyping of circulating CD8+ T cell subsets in human cutaneous leishmaniasis
Khamesipour, A., Rostami, M. N., Tasbihi, M., Mohammadi, A. M., Shahrestani, T., Sarrafnejad, A., Sohrabi, Y., Eskandari, S. E., & Valian, H. K. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.02.006 · Cited by 29
Metadata
- Authors
- Kaech, S. M., Wherry, E. J., & Ahmed, R.
- Affiliations
- Emory University (US)
- Corresponding author
- Ahmed, Rafi
- Venue
- Nature Reviews Immunology
- Published
- 2002-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 251-262
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2170904230
- Cited by
- 1,865
- References
- 137
- Citations by year
- 2026: 54 · 2025: 91 · 2024: 94 · 2023: 96 · 2022: 101 · 2021: 73 · 2020: 50 · 2019: 48 · 2018: 45 · 2017: 61 · 2016: 62 · 2015: 62 · 2014: 81 · 2013: 65 · 2012: 64
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- effector T cells, memory T cells, T cell differentiation, CD4+ T cells, CD8+ T cells, T cell proliferation, antigen stimulation, vaccine design
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunologic Memory, T-Lymphocytes, Vaccines, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.